4.7 Article

HIV-tat-mediated BCl-XL delivery protects retinal ganglion cells during experimental autoimmune optic neuritis

Journal

NEUROBIOLOGY OF DISEASE
Volume 20, Issue 2, Pages 218-226

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.nbd.2005.03.003

Keywords

tat-Bcl-X-L; Bcl-2 family; experimental autoimmune encephalomyelitis; neuroprotection; retinal ganglion cells; visual evoked potentials

Categories

Ask authors/readers for more resources

In multiple sclerosis (MS), post-mortem studies of human brain tissue as well as data from animal models have shown that apoptosis of neurons occurs to a significant extent during this disease. As neurodegeneration in MS correlates with permanent neurological deficits in patients, understanding the mechanisms would be an important precondition for designing appropriate neuroprotective therapies. Myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis often affects the optic nerve and leads to consecutive apoptosis of retinal ganglion cells (RGCs), the neurons that form its axons. In this study, we fused Bcl-X-L to the protein transduction domain of the HIV-transactivator of transcription. Thereby, this antiapoptotic member of the Bcl-2 family was delivered into RGCs of rats with electrophysiologically diagnosed optic neuritis. Transduction of Bel-XI, in our study led to significant rescue of RGCs indicating the relevance of this pathway for neuronal survival under autoimmune inflammatory conditions. (c) 2005 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available